Study ID: BDB-AS-304
Study Title
- A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
Teva Identifier
- BDB-AS-304
ClinicalTrials.gov Identifier
- NCT02040779
Study Status
- Completed
Trial Condition(s)
- Persistent Asthma
Interventions
- Drug: Beclomethasone dipropionate breath-actuated inhaler | Drug: Placebo breath-actuated inhaler | Drug: albuterol/salbutamol
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- December 26, 2013 - December 24, 2014
Phase
- Phase 3
Study Type
Interventional